CST Is Epistatic With Shieldin to Limit DNA Double‐Strand Break End Resection and Promote Repair During Igh Class Switch Recombination
European Journal of Immunology · 2025
DOI: 10.1002/eji.202451585 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Chloé Lescale und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institut Pasteur, Université Paris Cité, INSERM U1223, Genome Integrity Immunity and Cancer Unit, Équipe Labellisée Ligue Contre Le Cancer, Paris, Fr…. Hauptthemen laut MEDLINE: Immunoglobulin Class Switching, DNA Breaks, Double-Stranded, Immunoglobulin Heavy Chains, B-Lymphocytes. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ligue Contre le Cancer, Agence Nationale de la Recherche, Institut National Du Cancer.
Abstract (Originalsprache)
Downstream of 53BP1‐RIF1 lies the Shieldin (SHLD) protein complex, which comprises MAD2L2/REV7, SHLD3, SHLD2, and SHLD1, and the CTC1‐STN1‐TEN1 (CST) complex. During immunoglobulin heavy‐chain ( Igh ) class switch recombination (CSR), 53BP1‐RIF1‐SHLD promotes productive end‐joining by limiting resection of activation‐induced cytidine deaminase (AID)‐generated DNA double‐strand break (DSB) ends. The precise role of the CST complex and its interplay with SHLD during CSR is however elusive. Here, we established AID‐inducible B cell lines deficient for CTC1, SHLD1, or both and analyzed CSR in these cells. We show that stimulated CTC1‐deficient B cells are defective for IgM‐to‐IgA class switching, accumulate Igh chromosome breaks and translocations, and display increased end‐resection and micro‐homology usage at switching sites, demonstrating that CTC1 is essential to suppress alternative end‐joining during CSR. We show that CTC1 and SHLD1 are epistatic in preventing exacerbated DNA end resection and genetic instability during CSR. Moreover, using a complementation approach in Shld1 knockout splenic B cells, we show that a SHLD1 mutant defective in CST binding (SHLD1 ΔLDLP ) is fully proficient for IgM‐to‐IgG1, IgG2b, IgG3, and IgA class switching, thus demonstrating that the SHLD1‐CTC1 interaction through this motif is dispensable for CST and SHLD functions in promoting CSR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut Pasteur, Université Paris Cité, INSERM U1223, Genome Integrity Immunity and Cancer Unit, Équipe Labellisée Ligue Contre Le Cancer, Paris, France.
- Institut Pasteur, Université Paris Cité, Bioinformatics and Biostatistics Hub, Paris, France.
ORCID-Profile: Chloé Lescale, Timea Marton, Amaury Vaysse, Estelle Vincendeau, Alice Libri, François Dossin, Ludovic Deriano
Förderung
- Ligue Contre le Cancer
- Agence Nationale de la Recherche
- Institut National Du Cancer
Zitieren
APA
Lescale, C., Marton, T., Vaysse, A., Rode, G., Vincendeau, E., Libri, A., Dossin, F., & Deriano, L. (2025). CST Is Epistatic With Shieldin to Limit DNA Double‐Strand Break End Resection and Promote Repair During Igh Class Switch Recombination. European Journal of Immunology. https://doi.org/10.1002/eji.202451585
Vancouver
Lescale C, Marton T, Vaysse A, Rode G, Vincendeau E, Libri A, et al. CST Is Epistatic With Shieldin to Limit DNA Double‐Strand Break End Resection and Promote Repair During Igh Class Switch Recombination. European Journal of Immunology. 2025. doi:10.1002/eji.202451585
BibTeX
@article{Lescale2025,
author = {Lescale, Chloé and Marton, Timea and Vaysse, Amaury and Rode, Guillaume and Vincendeau, Estelle and Libri, Alice and Dossin, François and Deriano, Ludovic},
title = {CST Is Epistatic With Shieldin to Limit DNA Double‐Strand Break End Resection and Promote Repair During Igh Class Switch Recombination},
journal = {European Journal of Immunology},
year = {2025},
doi = {10.1002/eji.202451585}
}
EUVIMED